Short answer
DELCATH SYSTEMS, INC. (DCTH) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026.
DELCATH SYSTEMS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026
- Exhibit 99.1 contains the substantive results and operating update investors should review
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $35.1M, up from $20.6M, led by HEPZATO revenue of $32.7M
- Net income $7.0M versus $0.8M, with adjusted EBITDA $11.5M versus $5.3M
- Gross margin expanded to 89% from 87%, supporting improved operating leverage
- Cash and investments $104.3M with no debt, providing funding for commercial expansion and clinical development
- 2026 revenue guidance raised to $115M-$117M, implying HEPZATO volume growth of at least 41% over 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DELCATH SYSTEMS, INC. 8-K filings
Get the next DCTH 8-K as it lands
Follow DCTH for push alerts, or ask the research agent what this filing means.